Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging

Journal of Child Neurology

Volumn 16, Issue 9, 2001, Pages 636-641

  Rosenberg, David R ^a,b   Amponsah, Akua ^a   Sullivan, April ^a   MacMillan, Shauna ^a   Moore, Gregory J ^a,b  

^a Departments of Psychiatry and Behavioral Neurosciences   (United Kingdom)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID;

ADOLESCENT; ARTICLE; BRAIN LEVEL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CYTOSOL; DIAGNOSTIC IMAGING; HUMAN; MENTAL PATIENT; METHODOLOGY; NERVE CELL; OBSESSION; PATHOPHYSIOLOGY; PHANTOM; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCHOOL CHILD; SPECTROSCOPY; THALAMUS;

ADOLESCENT; ASPARTIC ACID; BRAIN MAPPING; CASE-CONTROL STUDIES; CHILD; CHOLINE; CREATINE; CYTOSOL; DOMINANCE, CEREBRAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OBSESSIVE-COMPULSIVE DISORDER; REFERENCE VALUES; THALAMUS;

EID: 0034780286     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380101600902     Document Type: Article

References (66)

1. Neurobiology of childhood obsessive-compulsive disorder
2. Toward a neurodevelopmental model of obsessive compulsive disorder
3. Neurological examination
4. Obsessional states: A study in the relationship between abnormalities occurring at birth and subsequent development of obsessional symptoms
5. After effects of brain injuries
6. Obsessive compulsive symptomatology in children with Tourette's syndrome
7. The organic background of obsessions and compulsions
8. Neuro-psychological study of pediatric obsessive compulsive disorder
9. Cortical development and thalamic pathology
10. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder
11. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder
12. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography
13. 18F] FDG PET study in obsessive-compulsive disorder: A clinical/metabolic correlation study after treatment
14. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions
15. Functional anatomy of obsessive-compulsive phenomena
16. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals
17. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine
18. N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain, review
19. Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra
20. Specific expression of N-acetylaspartate in neurons, oligodendrocyte type 2 astrocyte progenitors, and immature oligodendrocytes in vitro
21. N-acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging
22. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive compulsive disorder and comparison subjects
23. 1-H-magnetic resonance spectroscopy in obsessive-compulsive disorder: Evidence for neuronal loss in the cingulate gyrus and the right striatum
24. Decrease in caudate glutamatergic concentrations in pediatric obsessive compulsive disorder patients taking paroxetine
25. Priority communication. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive compulsive disorder
26. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data
27. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity
28. Fast proton spectroscopic imaging of human brain using multiple spin-echoes
29. Quantitation of automated single-voxel proton MRS using cerebral water at an internal reference
30. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging
31. PET and MRI of the thalamus in never-medicated patients with schizophrenia
32. Thalamic abnormalities in schizophrenics visualized through magnetic resonance image averaging
33. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics
34. Partial volume decrease of the thalamus in relatives of patients with schizophrenia
35. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T
36. Proton magnetic resonance spectroscopy in pediatric neuroradiology
37. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations
38. 1H MRS choline: Correlation with in vitro chemistry/histology
39. Recycling the cholines, abstract
40. Choline and cholinergic neurons
41. Receptor regulation of choline phospholipid hydrolysis. A novel source of diaglycerol and phosphatidic acid
42. Clinical applications of magnetic resonance spectroscopy
43. What might be the impact on neurobiology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
44. Magnetic resonance spectroscopy in affective disorders
45. Hormonal regulation of phosphatidylcholine breakdown
46. Phosphatidylcholine breakdown and signal transduction
47. Choline phospholipids: Signal transduction and carcinogenesis
48. The inhibition of diacyl-glycerol-stimulated intracellular phospholipases by phospholipids with a phosphocholine-containing polar group. A possible physiological role for sphingomyelin
49. Molecular approaches to child psychopathology
50. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient
51. Urinary free cortisol levels in obsessive-compulsive disorder
52. The role of central oxytocin in obsessive compulsive disorder and related normal behavior
53. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder
54. Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment
55. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: Evidence for a gender-related effect
56. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder
57. Brain metabolic alterations in Cushing's syndrome as monitored by proton magnetic resonance spectroscopy
58. Brain metabolic changes on in vivo proton magnetic resonance spectroscopy in children with congenital hypothyroidism
59. Frontal lobe proton magnetic resonance spectroscopy in Graves' disease: A pilot study
60. Myoinositol, choline and mood in bipolar disorder: A proton MRSI study of anterior cingulate cortex
61. Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study
62. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton MRS